Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium: a sub-analysis of the PROPHESYS study.

Mulkay JP, Bourgeois S, Lasser L, De Galocsy C, Tomasovic S, Horsmans Y, Van Vlierberghe H; Belgian PROPHESYS investigators. Acta Gastroenterol Belg. 2014 Mar;77(1):30-40.

Voir l’article

← Retour aux publications